Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

103 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Similar alterations of the stratum corneum ceramide profile in atopic dermatitis, psoriasis and ichthyosis: results from a systematic review and meta-analysis.
Rousel J, Mergen C, Schoones JW, Niemeyer-van der Kolk T, van Doorn MBA, Bouwstra JA, van Smeden J, Rissmann R; Next Generation ImmunoDermatology Consortium. Rousel J, et al. Among authors: van doorn mba. J Invest Dermatol. 2024 Mar 4:S0022-202X(24)00168-4. doi: 10.1016/j.jid.2024.02.010. Online ahead of print. J Invest Dermatol. 2024. PMID: 38447864 No abstract available.
Impairment in work and activities of daily life in patients with psoriasis: results of the prospective BioCAPTURE registry.
van Hal TW, van den Reek JMPA, Wenink MH, Otero ME, Ossenkoppele PM, Njoo MD, Oostveen A, Peters B, Tjioe M, Kop EN, Körver JEM, Dodemont SRP, Kleinpenning MM, Berends MAM, Veldkamp WR, van Doorn MBA, Mommers JM, Lindhout RJ, Kuijpers ALA, van Lümig PP, de Jonge CEJ, Tupker RA, Hendricksen J, Keijsers RR, van den Hoogen FHJ, Vriezekolk JE, de Jong EMGJ. van Hal TW, et al. Among authors: van doorn mba. J Dermatolog Treat. 2024 Dec;35(1):2304025. doi: 10.1080/09546634.2024.2304025. Epub 2024 Jan 23. J Dermatolog Treat. 2024. PMID: 38263716 Free article.
Lesional skin of seborrheic dermatitis patients is characterized by skin barrier dysfunction and correlating alterations in the stratum corneum ceramide composition.
Rousel J, Nădăban A, Saghari M, Pagan L, Zhuparris A, Theelen B, Gambrah T, van der Wall HEC, Vreeken RJ, Feiss GL, Niemeyer-van der Kolk T, Burggraaf J, van Doorn MBA, Bouwstra JA, Rissmann R. Rousel J, et al. Among authors: van doorn mba. Exp Dermatol. 2024 Jan;33(1):e14952. doi: 10.1111/exd.14952. Epub 2023 Nov 16. Exp Dermatol. 2024. PMID: 37974545
Home-Use Hyaluronic Acid Jet Injectors: Unreliable and Unsafe.
Juch RNS, Bik L, Boeijink N, de Vos J, Dobbe IJGG, Bloemen PR, van Doorn MBA, Velthuis P, Aalders MCG, Wolkerstorfer A. Juch RNS, et al. Among authors: van doorn mba. Dermatol Surg. 2024 Jan 1;50(1):62-68. doi: 10.1097/DSS.0000000000003971. Epub 2023 Oct 5. Dermatol Surg. 2024. PMID: 37815475
Guselkumab induction therapy demonstrates long-lasting efficacy in patients with mild psoriasis, results from a randomized, placebo-controlled exploratory clinical trial.
Rousel J, Bergmans ME, van der Meulen LWJ, Pagan L, de Bruin DT, de Kam ML, Klarenbeek NB, Bouwstra JA, Seyger MMB, van den Reek JMPA, Niemeyer-van der Kolk T, Rissmann R, van Doorn MBA; NGID consortium. Rousel J, et al. Among authors: van doorn mba. J Am Acad Dermatol. 2024 Feb;90(2):395-397. doi: 10.1016/j.jaad.2023.09.071. Epub 2023 Oct 5. J Am Acad Dermatol. 2024. PMID: 37804933 Free article. Clinical Trial. No abstract available.
Treatment with the Topical Antimicrobial Peptide Omiganan in Mild-to-Moderate Facial Seborrheic Dermatitis versus Ketoconazole and Placebo: Results of a Randomized Controlled Proof-of-Concept Trial.
Rousel J, Saghari M, Pagan L, Nădăban A, Gambrah T, Theelen B, de Kam ML, Haakman J, van der Wall HEC, Feiss GL, Niemeyer-van der Kolk T, Burggraaf J, Bouwstra JA, Rissmann R, van Doorn MBA. Rousel J, et al. Among authors: van doorn mba. Int J Mol Sci. 2023 Sep 20;24(18):14315. doi: 10.3390/ijms241814315. Int J Mol Sci. 2023. PMID: 37762625 Free PMC article. Clinical Trial.
Urticaria exacerbations and adverse reactions in patients with chronic urticaria receiving COVID-19 vaccination: Results of the UCARE COVAC-CU study.
Kocatürk E, Salameh P, Sarac E, Vera Ayala CE, Thomsen SF, Zuberbier T, Ensina LF, Popov TA, van Doorn MBA, Giménez-Arnau AM, Asero R, Criado PR, Aarestrup FM, AbdulHameed Ansari Z, Al Abri S, Al-Ahmad M, Al Hinai B, Allenova A, Al-Nesf M, Altrichter S, Arnaout R, Bartosińska J, Bauer A, Bernstein JA, Bizjak M, Bonnekoh H, Bouillet L, Brzoza Z, Calvalcanti Dela Bianca Melo AC, Campinhos FL, Carne E, Purayil SC, Cherrez-Ojeda I, Chong-Neto HJ, Christoff G, Conlon N, Jardim Criado RF, Cvenkel K, Damadoglu E, Danilycheva I, Day C, de Montjoye L, Demir S, Ferucci SM, Fomina D, Fukunaga A, Garcia E, Gelincik A, Göbel JH, Godse K, Gonçalo M, Gotua M, Grattan C, Gugala A, Guillet C, Kalyoncu AF, Karakaya G, Kasperska-Zając A, Katelaris CH, Khoshkhui M, Kleinheinz A, Kolacinska-Flont M, Kolkhir P, Košnik M, Krasowska D, Kumaran MS, Kuprys-Lipinska I, Kurowski M, Kuznetsova EV, Larenas-Linnemann D, Lebedkina MS, Lee Y, Makris M, Gómez RM, Nasr I, Neisinger S, Oda Y, Kara RÖ, Palitot EB, Papapostolou N, Salvador Parisi CA, Pesque D, Peter J, Petkova E, Ridge K, Rudenko M, Rutkowski K, Saini SS, Salman A, Sanchez J, Şekerel B, Serdotetskova SA, Serpa FS, Dikicier BS, Sidiropoulos N, S… See abstract for full author list ➔ Kocatürk E, et al. Among authors: van doorn mba. J Allergy Clin Immunol. 2023 Nov;152(5):1095-1106. doi: 10.1016/j.jaci.2023.07.019. Epub 2023 Aug 12. J Allergy Clin Immunol. 2023. PMID: 37574079
103 results